{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:12:22Z","timestamp":1785528742083,"version":"3.56.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The spectrum of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) represents highly inflammatory rheumatic diseases. Patients mostly report severe physical impairment. Possible consequences for mental health have been scarcely studied. The aim of this study was to investigate psychological well-being in the context of GCA and PMR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cross-sectional study with <jats:italic>N<\/jats:italic>\u2009=\u2009100 patients with GCA and\/or PMR (GCA-PMR). Patient-reported outcomes (PROs) were measured using the Short Form 36 Version 2 (SF-36v2) and visual analog scale (VAS) assessment. Moreover, the Patient Health Questionnaire 9 (PHQ-9) was used in 35 of 100 patients to detect depression. To compare PROs with physician assessment, VAS was also rated from physician perspective. To assess a possible association with inflammation itself, serological parameters of inflammation (C-reactive protein [CRP], erythrocyte sedimentation rate [ESR]) were included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In all scales of the SF-36v2 except General Health (GH) and in the physical and mental sum score (PCS, MCS), a significant impairment compared to the German reference collective was evident (MCS: d\u2009=\u20090.533, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). In the PHQ-9 categorization, 14 of the 35 (40%) showed evidence of major depression disorder. VAS Patient correlated significantly with PHQ-9 and SF-36 in all categories, while VAS Physician showed only correlations to physical categories and not in the mental dimensions. Regarding inflammatory parameters, linear regression showed CRP to be a complementary significant positive predictor of mental health subscale score, independent of pain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>PRO show a relevant impairment of mental health up to symptoms of major depression disorder. The degree of depressive symptoms is also distinctly associated with the serological inflammatory marker CRP.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1146815","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:04:47Z","timestamp":1685455487000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis"],"prefix":"10.3389","volume":"10","author":[{"given":"Matthias","family":"Froehlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Zahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gernert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick-Pascal","family":"Strunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Hueper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Portegys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Christina","family":"Schwaneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottar","family":"Gadeholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"K\u00fcbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hewig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Ziebell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"ard-2022-223429","DOI":"10.1136\/ard-2022-223429","article-title":"Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"kew273","DOI":"10.1093\/rheumatology\/kew273","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrrheum.2012.97","article-title":"Clinical features of polymyalgia rheumatica and giant cell arteritis","volume":"8","author":"Salvarani","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"key":"ref6","first-page":"273","article-title":"Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988","volume":"19","author":"Franz\u00e9n","year":"1992","journal-title":"J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1056\/NEJMcp1214825","article-title":"Clinical practice. Giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia Rheumatica and Giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/089198879701000403","article-title":"Psychiatric aspects of temporal arteritis: a case report and review of the literature","volume":"10","author":"Johnson","year":"1997","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e017073","DOI":"10.1136\/bmjopen-2017-017073","article-title":"What is the impact of giant cell arteritis on patients' lives? A UK qualitative study","volume":"7","author":"Liddle","year":"2017","journal-title":"BMJ Open"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/ageing\/afaa010","article-title":"A curable pseudo-dementia related to an atypical presentation of giant cell arteritis","volume":"49","author":"Lahaye","year":"2020","journal-title":"Age Ageing"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/anr.1780321017","article-title":"Mental status abnormalities in temporal arteritis: a treatable cause of dementia in the elderly","volume":"32","author":"Pascuzzi","year":"1989","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/MD.0b013e3181908e96","article-title":"Stroke and multi-infarct dementia as presenting symptoms of Giant cell arteritis: report of 7 cases and review of the literature","volume":"87","author":"Solans-Laqu\u00e9","year":"2008","journal-title":"Medicine"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/acr.20132","article-title":"Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis","volume":"62","author":"Barton","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1055\/s-2003-41645","article-title":"Der SF-36 in der rehabilitationswissenschaftlichen Forschung - Ergebnisse aus dem Norddeutschen Verbund f\u00fcr Rehabilitationsforschung (NVRF) im F\u00f6rderschwerpunkt Rehabilitationswissenschaften","volume":"42","author":"Bullinger","year":"2003","journal-title":"Rehabilitation (Stuttg)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00038-005-4090-6","article-title":"Die Version 2.0 des SF-36 Health Survey - Ergebnisse einer bev\u00f6lkerungsrepr\u00e4sentativen Studie","volume":"50","author":"Morfeld","year":"2005","journal-title":"Soz Praventivmed"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MDThe PHQ primary care study","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/occmed\/kqt154","article-title":"PHQ-9","volume":"64","author":"Williams","year":"2014","journal-title":"Occup Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1007\/s11606-007-0333-y","article-title":"Screening for depression in medical settings with the patient health questionnaire (PHQ): a diagnostic Meta-analysis","volume":"22","author":"Gilbody","year":"2007","journal-title":"J Gen Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/00006199-198909000-00006","article-title":"Visual analogue scales: measurement of subjective phenomena","volume":"38","author":"Gift","year":"1989","journal-title":"Nurs Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1055\/s-2007-1019515","article-title":"Zur Reliabilit\u00e4t und Validit\u00e4t der Stimmungsmessung mit der Visuellen Analog-Skala (VAS)","volume":"15","author":"F\u00e4hndrich","year":"1982","journal-title":"Pharmacopsychiatry"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10597-019-00469-7","article-title":"A single-item visual analogue scale (VAS) measure for assessing depression among college students","volume":"56","author":"Huang","year":"2020","journal-title":"Community Ment Health J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/occmed\/kqs140","article-title":"Clinical stress assessment using a visual analogue scale","volume":"62","author":"Lesage","year":"2012","journal-title":"Occup Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00103-013-1700-y","article-title":"Gesundheitsbezogene Lebensqualit\u00e4t bei Erwachsenen in Deutschland","volume":"56","author":"Ellert","year":"2013","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/B978-0-12-179060-8.50009-8","article-title":"CHAPTER 4 - differences between correlation coefficients","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1977"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.genhosppsych.2013.04.006","article-title":"Standardization of the depression screener patient health questionnaire (PHQ-9) in the general population","volume":"35","author":"Kocalevent","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"777310","DOI":"10.3389\/fmed.2021.777310","article-title":"Impact of Giant cell arteritis and its treatment on the Patient's quality of life: a single-center self-assessment study","volume":"8","author":"de Boysson","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/ijms23031616","article-title":"C-reactive protein as a biomarker for major depressive disorder?","volume":"23","author":"Orsolini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbi.2018.05.012","article-title":"The association of disease activity, pro-inflammatory cytokines, and neurotrophic factors with depression in patients with rheumatoid arthritis","volume":"73","author":"Cheon","year":"2018","journal-title":"Brain Behav Immun"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s10067-022-06174-3","article-title":"Inflammatory markers and risk factors of RA patients with depression and application of different scales in judging depression","volume":"41","author":"Li","year":"2022","journal-title":"Clin Rheumatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.1503\/cmaj.110829","article-title":"Optimal cut-off score for diagnosing depression with the patient health questionnaire (PHQ-9): a meta-analysis","volume":"184","author":"Manea","year":"2012","journal-title":"Can Med Assoc J"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semarthrit.2011.12.003","article-title":"Differences in the patient's and the physician's perspective of disease in psoriatic arthritis","volume":"42","author":"Dandorfer","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"c186","DOI":"10.1136\/bmj.c186","article-title":"The routine use of patient reported outcome measures in healthcare settings","volume":"340","author":"Dawson","year":"2010","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1001\/jama.288.23.3027","article-title":"Health-related quality-of-life assessments and patient-physician CommunicationA randomized controlled trial","volume":"288","author":"Detmar","year":"2002","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s11606-016-3980-z","article-title":"A multilevel analysis of patient engagement and patient-reported outcomes in primary care practices of accountable care organizations","volume":"32","author":"Shortell","year":"2017","journal-title":"J Gen Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMp1707537","article-title":"Making patients and doctors happier \u2014 the potential of patient-reported outcomes","volume":"377","author":"Rotenstein","year":"2017","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2147\/prom.s156291","article-title":"PROMs data: can it be used to make decisions for individual patients? A narrative review","volume":"10","author":"Field","year":"2019","journal-title":"Patient Relat Outcome Meas"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3899\/jrheum.181072","article-title":"Update on outcome measure development in large-vessel Vasculitis: report from OMERACT 2018","volume":"46","author":"Aydin","year":"2019","journal-title":"J Rheumatol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1093\/rheumatology\/keab076","article-title":"Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure","volume":"60","author":"Robson","year":"2021","journal-title":"Rheumatology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1530\/joe-18-0226","article-title":"Corticosteroids and the brain","volume":"238","author":"Jo\u00ebls","year":"2018","journal-title":"J Endocrinol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jad.2018.07.021","article-title":"The interrelations among aspects of dyspnea and symptoms of depression in COPD patients - a network analysis","volume":"240","author":"Schuler","year":"2018","journal-title":"J Affect Disord"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1146815\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:04:53Z","timestamp":1685455493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1146815\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":44,"alternative-id":["10.3389\/fmed.2023.1146815"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1146815","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"article-number":"1146815"}}